We are live on ! Find out more
FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Fund
S&P 500
This Quarter Est. Return
+27.95%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
AUM
$49.5M
AUM Growth
-$435K
Cap. Flow
-$12.9M
Cap. Flow %
-26.09%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1
10x Genomics
TXG
$5.87B
$49.5M 100%
1,358,528
-395,000
-23% -$12.9M

Similar funds

Foresite Capital Management II's Q4 2022 Portfolio in Review

As of Q4 2022, Foresite Capital Management II held 1 position worth $49.5M, down 0.87% from $49.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management II withdrew a net $12.9M in Q4 2022, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management II's biggest Q4 2022 reduction was 10x Genomics, cutting an estimated $12.9M.
  • Foresite Capital Management II's ten largest holdings make up 100% of its $49.5M portfolio in Q4 2022.
  • Foresite Capital Management II opened 0 new positions and closed 0 in Q4 2022.
  • Foresite Capital Management II's portfolio value fell 0.87% quarter-over-quarter to $49.5M.

Based on Foresite Capital Management II's 13F filing for Q4 2022, filed 13 Feb 2023.